Haralick纹理特征用于预测结直肠癌治疗反应:初步研究
本研究纳入8例结直肠癌患者,基于新辅助放化疗前斜轴T2加权MRI图像,由两名放射科医生共识勾画肿瘤ROI,从归一化灰度共生矩阵四个方向提取192个Haralick特征中的14个。结果显示14个特征中有5个在完全缓解组与非缓解组间差异有统计学意义(p < 0.05),作者认为这些特征可能作为额外的影像生物标志物用于结直肠癌的肿瘤学管理。
要点
- 新辅助放化疗前T2加权MRI的Haralick纹理分析中,14个特征有5个与治疗反应显著相关(p < 0.05)。
- 显著特征为能量、对比度、相关性、熵和逆差矩。
- 作者认为这些特征可能作为额外的影像生物标志物用于结直肠癌患者的肿瘤学管理。
核心结论
- 14个Haralick特征中有5个在预测结直肠癌治疗反应方面显示出显著相关性,可能作为额外的影像生物标志物用于结直肠癌患者的肿瘤学管理。
研究设计与样本
- 初步研究,纳入8例结直肠癌患者,经MRI和组织学评估后根据对新辅助放化疗的反应分为完全缓解组和非缓解组;由两名放射科医生共识在放化疗前斜轴T2加权MRI序列上围绕肿瘤勾画ROI,从归一化灰度共生矩阵四个方向提取192个Haralick特征中的14个,并进行专门统计分析计算均值和标准差。
诊断标准与关键数值
- 放化疗前MRI检查显示,14个计算的Haralick纹理特征中有5个具有显著价值(p < 0.05),显著特征为能量、对比度、相关性、熵和逆差矩。
临床应用与阅片要点
- 作者认为这5个Haralick特征可能作为额外的影像生物标志物用于结直肠癌患者的肿瘤学管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Haralick features Texture analysis is a recent oncologic imaging biomarker used to assess quantitatively the heterogeneity within a tumor. The aim of this study is to evaluate which Haralick's features are the most feasible in predicting tumor response to neoadjuvant chemoradiotherapy (CRT) in colorectal cancer.
MATERIALS AND METHODS: After MRI and histological assessment, eight patients were enrolled and divided into two groups based on response to neoadjuvant CRT in complete responders (CR) and non-responders (NR). Oblique Axial T2-weighted MRI sequences before CRT were analyzed by two radiologists in consensus drawing a ROI around the tumor. 14 over 192 Haralick's features were extrapolated from normalized gray-level co-occurrence matrix in four different directions. A dedicated statistical analysis was performed to evaluate distribution of the extracted Haralick's features computing mean and standard deviation.
RESULTS: Pretreatment MRI examination showed significant value (p < 0.05) of 5 over 14 computed Haralick texture. In particular, the significant features are the following: concerning energy, contrast, correlation, entropy and inverse difference moment.
CONCLUSIONS: Five Haralick's features showed significant relevance in the prediction of response to therapy in colorectal cancer and might be used as additional imaging biomarker in the oncologic management of colorectal patients.
引用
- Caruso D, Zerunian M, Ciolina M, et al. Haralick's texture features for the prediction of response to therapy in colorectal cancer: a preliminary study. Radiol Med. 2017. PMID: 29119525. doi:10.1007/s11547-017-0833-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。